199 related articles for article (PubMed ID: 30097523)
21. Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI.
Förster A; Brehmer S; Seiz-Rosenhagen M; Mildenberger I; Giordano FA; Wenz H; Reuss D; Hänggi D; Groden C
J Neurooncol; 2019 Mar; 142(1):103-109. PubMed ID: 30565029
[TBL] [Abstract][Full Text] [Related]
22. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Mattox AK; Lark AL; Adamson DC
Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
[TBL] [Abstract][Full Text] [Related]
23. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
[TBL] [Abstract][Full Text] [Related]
24. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
25. Gliomatosis cerebri: improved outcome with radiotherapy.
Perkins GH; Schomer DF; Fuller GN; Allen PK; Maor MH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1137-46. PubMed ID: 12829152
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging features of canine gliomatosis cerebri.
Schweizer-Gorgas D; Henke D; Oevermann A; Lang J; Vandevelde M; Steffen F
Vet Radiol Ultrasound; 2018 Mar; 59(2):180-187. PubMed ID: 29110365
[TBL] [Abstract][Full Text] [Related]
27. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.
Kaloshi G; Guillevin R; Martin-Duverneuil N; Laigle-Donadey F; Psimaras D; Marie Y; Mokhtari K; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Aug; 73(6):445-9. PubMed ID: 19667319
[TBL] [Abstract][Full Text] [Related]
28. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract][Full Text] [Related]
29. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.
Taillibert S; Chodkiewicz C; Laigle-Donadey F; Napolitano M; Cartalat-Carel S; Sanson M
J Neurooncol; 2006 Jan; 76(2):201-5. PubMed ID: 16200347
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy approach in gliomatosis cerebri--case reports and literature review.
Horst E; Micke O; Romppainen ML; Pyhtinen J; Paulus W; Schäfer U; Rübe C; Willich N
Acta Oncol; 2000; 39(6):747-51. PubMed ID: 11130015
[TBL] [Abstract][Full Text] [Related]
31. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
32. Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.
Kibe Y; Motomura K; Ohka F; Aoki K; Shimizu H; Yamaguchi J; Nishikawa T; Saito R
Sci Rep; 2023 Jan; 13(1):23. PubMed ID: 36646712
[TBL] [Abstract][Full Text] [Related]
33. CT and MRI findings in gliomatosis cerebri: a neuroradiologic and neuropathologic review of diffuse infiltrating brain neoplasms.
Freund M; Hähnel S; Sommer C; Martmann M; Kiessling M; Tronnier V; Sartor K
Eur Radiol; 2001; 11(2):309-16. PubMed ID: 11218033
[TBL] [Abstract][Full Text] [Related]
34. Gliomatosis cerebri: neurobehavioral and neuropathological observations.
Filley CM; Kleinschmidt-DeMasters BK; Lillehei KO; Damek DM; Harris JG
Cogn Behav Neurol; 2003 Sep; 16(3):149-59. PubMed ID: 14501536
[TBL] [Abstract][Full Text] [Related]
35. ¹¹C-Methionine or ¹¹C-Choline PET is superior to MRI in the evaluation of gliomatosis cerebri.
Cai L; Gao S; Li Y; Lu D
Clin Nucl Med; 2011 Feb; 36(2):127-9. PubMed ID: 21220976
[TBL] [Abstract][Full Text] [Related]
36. Clinical diagnosis of gliomatosis cerebri: report of three cases.
Akimoto J; Nishioka H; Miki T; Haraoka J; Kudo M
Brain Tumor Pathol; 2004; 21(2):87-95. PubMed ID: 15700839
[TBL] [Abstract][Full Text] [Related]
37. Gliomatosis cerebri.
Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
[TBL] [Abstract][Full Text] [Related]
38. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
Villanueva-Meyer JE; Wood MD; Choi BS; Mabray MC; Butowski NA; Tihan T; Cha S
AJR Am J Roentgenol; 2018 Mar; 210(3):621-628. PubMed ID: 29261348
[TBL] [Abstract][Full Text] [Related]
39. Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France.
Greenfield JP; Castañeda Heredia A; George E; Kieran MW; Morales La Madrid A
Pediatr Blood Cancer; 2016 Dec; 63(12):2072-2077. PubMed ID: 27466787
[TBL] [Abstract][Full Text] [Related]
40. Histological and MR correlations in Gliomatosis cerebri.
Peretti-Viton P; Brunel H; Chinot O; Daniel C; Barrié M; Bouvier C; Figarella-Branger D; Fuentes S; Dufour H; Grisoli F
J Neurooncol; 2002 Sep; 59(3):249-59. PubMed ID: 12241123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
